122 related articles for article (PubMed ID: 37039149)
21. p53 alterations in atypical alveolar hyperplasia of the human lung.
Slebos RJ; Baas IO; Clement MJ; Offerhaus GJ; Askin FB; Hruban RH; Westra WH
Hum Pathol; 1998 Aug; 29(8):801-8. PubMed ID: 9712420
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
Hurr K; Kemp B; Silver SA; el-Naggar AK
Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
[TBL] [Abstract][Full Text] [Related]
23. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
[TBL] [Abstract][Full Text] [Related]
24. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
[TBL] [Abstract][Full Text] [Related]
25. Nuclear overexpression of the E2F3 transcription factor in human lung cancer.
Cooper CS; Nicholson AG; Foster C; Dodson A; Edwards S; Fletcher A; Roe T; Clark J; Joshi A; Norman A; Feber A; Lin D; Gao Y; Shipley J; Cheng SJ
Lung Cancer; 2006 Nov; 54(2):155-62. PubMed ID: 16938365
[TBL] [Abstract][Full Text] [Related]
26. Carcinomas of the lung with neuroendocrine differentiation.
Carter D; Yesner R
Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
[TBL] [Abstract][Full Text] [Related]
27. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of neural-cadherin in pulmonary epithelial tumours.
Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
[TBL] [Abstract][Full Text] [Related]
29. Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas.
Schmid K; Angerstein N; Geleff S; Gschwendtner A
Mod Pathol; 2006 Mar; 19(3):453-9. PubMed ID: 16462732
[TBL] [Abstract][Full Text] [Related]
30. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications.
Cagle PT; el-Naggar AK; Xu HJ; Hu SX; Benedict WF
Am J Pathol; 1997 Feb; 150(2):393-400. PubMed ID: 9033254
[TBL] [Abstract][Full Text] [Related]
31. Abnormal p53 expression in lung neuroendocrine tumors. Diagnostic and prognostic implications.
Roncalli M; Doglioni C; Springall DR; Papotti M; Pagani A; Polak JM; Ibrahim NB; Coggi G; Viale G
Diagn Mol Pathol; 1992 Jun; 1(2):129-35. PubMed ID: 1364172
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
[TBL] [Abstract][Full Text] [Related]
33. Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas.
Sunday ME; Choi N; Spindel ER; Chin WW; Mark EJ
Hum Pathol; 1991 Oct; 22(10):1030-9. PubMed ID: 1668786
[TBL] [Abstract][Full Text] [Related]
34. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung.
LaPoint RJ; Bourne PA; Wang HL; Xu H
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):401-6. PubMed ID: 18091382
[TBL] [Abstract][Full Text] [Related]
35. TTF-1 gene expression in human lung tumours.
Fabbro D; Di Loreto C; Stamerra O; Beltrami CA; Lonigro R; Damante G
Eur J Cancer; 1996 Mar; 32A(3):512-7. PubMed ID: 8814700
[TBL] [Abstract][Full Text] [Related]
36. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
[TBL] [Abstract][Full Text] [Related]
37. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.
Kaufmann O; Dietel M
Histopathology; 2000 May; 36(5):415-20. PubMed ID: 10792482
[TBL] [Abstract][Full Text] [Related]
38. Genetic changes in the spectrum of neuroendocrine lung tumors.
Onuki N; Wistuba II; Travis WD; Virmani AK; Yashima K; Brambilla E; Hasleton P; Gazdar AF
Cancer; 1999 Feb; 85(3):600-7. PubMed ID: 10091733
[TBL] [Abstract][Full Text] [Related]
39. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not.
Xu H; Bourne PA; Spaulding BO; Wang HL
Hum Pathol; 2007 Apr; 38(4):555-63. PubMed ID: 17316760
[TBL] [Abstract][Full Text] [Related]
40. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.
Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E
Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
